Muscular Dystrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with Duchenne Muscular Dystrophy (DMD):
- People who are male
- People aged 10 years or older
- People who have a confirmed diagnosis of DMD, shown through a muscle biopsy or genetic testing
- People aged 18 or older who can provide their own signed consent to participate
- People under 18 whose parent or guardian provides consent, and who also give their own agreement to participate
For healthy comparison participants (called "controls"):
- People who are male
- People aged 10 years or older
- People aged 18 or older who can provide their own signed consent to participate
- People under 18 whose parent or guardian provides consent, and who also give their own agreement to participate
- People whose body weight category (underweight, normal, overweight, or obese) matches that of a DMD participant in the study
- People whose self-reported race or ethnicity matches that of a DMD participant in the study
- People with no known diabetes, no abnormal fasting blood sugar, and no abnormal blood sugar response after eating — including people with a normal blood sugar marker (HbA1c below 5.7%), or people with a slightly elevated marker (5.7–6.4%) who have normal results on additional blood sugar testing (confirm with trial site)
Who may not be able to join:
- People who do not wish to participate
- People who have been diagnosed with diabetes before the study, or who have taken insulin or other diabetes medications within the 4 weeks before the study begins
- People who have a pacemaker, an implantable heart device (ICD), or any other implanted medical device
- People who, in the opinion of the study team, would be unable to follow the study procedures
- People who have a diagnosis of DMD or Becker muscular dystrophy (this applies to the healthy comparison group only)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jaclyn Tamaroff, MD, Vanderbilt University Medical Center
Phone: 615-875-7853
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of hyperglycemia; Standard deviation of the mean R-to-R segment (SDANN)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.